FDA Warning Letter — BioDiagnostic International

Case 554322 — FEI 2023751

The FDA took a Warning Letter action against BioDiagnostic International on Jul 12, 2018 (Brea, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
BioDiagnostic International
Date
Jul 12, 2018
Fiscal Year
2018
Product Type
Drugs
Center
CDER
Location
Brea, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.